PANews reported on September 9 that Nasdaq-listed Artelo Biosciences (NASDAQ: ARTL) announced the launch of an underwritten public offering of common stock and/or prepaid warrants, with RF Lafferty & Co., Inc. serving as the sole bookrunner.
Additionally, Artelo announced a $9.475 million private fundraising plan to launch its financial strategy based on the Solana blockchain, becoming one of the first companies to adopt the Solana cryptocurrency as its core reserve asset.
Author: PA一线
This content is for informational purposes only and does not constitute investment advice.
PA一线1 hour agoPA一线2 hour ago
Ten years have passed since the creation of Ethereum. Where is the "world computer" headed? This special feature will feature selected articles reviewing Ethereum's turbulent decade of rise, challenges, and breakthroughs.
Data analysis and visual communication of industry hot spots help users understand the meaning and opportunities behind each data.
Exclusive interviews with crypto celebrities, sharing unique observations and insights
The AI Agen innovation wave is sweeping the world. How will it take root in Web3? Let’s embark on this intelligent journey together
From joke culture to the trillion-dollar race, Memecoin has become an integral part of the crypto market. In this Memecoin super cycle, how can we seize the opportunity?
Bybit suffered a security incident, and funds worth $1.44 billion were withdrawn. A North Korean hacker group was accused of being the perpetrator.
